Advisors Asset Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
Advisors Asset Management's PCVX Position: Q3 2026 in Review
Advisors Asset Management reduced its Vaxcyte (PCVX) stake by 57% in Q3 2026, selling an estimated $63.8K and leaving 826 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #1347.
Advisors Asset Management first reported a position in PCVX in Q4 2024 and has held it in 8 quarters since. The position peaked at $112K in Q2 2026. 353 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- Advisors Asset Management held 826 shares of Vaxcyte worth $47K as of Q3 2026.
- Advisors Asset Management sold 1,095 Vaxcyte shares in Q3 2026, an estimated $63.8K.
- Vaxcyte made up ﹤0.01% of Advisors Asset Management's portfolio in Q3 2026, its #1347 holding.
- Advisors Asset Management first reported a position in Vaxcyte in Q4 2024 and has held it in 8 quarters since.
- Advisors Asset Management's Vaxcyte position peaked at $112K in Q2 2026.
- 353 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on Advisors Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.